672 Randomised phase II trial (M77001) of trastuzumab (Herceptin®) plus docetaxel versus docetaxel alone, as first-line therapy in patients with HER2-positive metastitic breast cancer
Open Access
- 30 September 2003
- journal article
- abstracts
- Published by Elsevier in European Journal of Cancer Supplements
- Vol. 1 (5) , S202
- https://doi.org/10.1016/s1359-6349(03)90703-8
Abstract
No abstract availableThis publication has 0 references indexed in Scilit: